The hottest Immunity Substack posts right now

And their main takeaways
Category
Top Health & Wellness Topics
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 13 Aug 21
  1. The previous plan of waiting for a vaccine and declaring victory is no longer feasible with the emergence of the Delta variant.
  2. In dealing with the Delta variant, it is important to flatten the curve to prevent overwhelming hospitals and buy time to vaccinate more people.
  3. Policies to address the Delta variant should include restrictions on non-essential gatherings, rapid testing in schools, encouraging mask-wearing, and providing support for those who cannot be vaccinated.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 21 Apr 21
  1. Experts predict the worst of the pandemic is yet to come in 2021-22, with potential outbreaks due to low vaccinations and new variants.
  2. The forecasts for Western Europe, Latin America, and the US all show challenges ahead in managing COVID-19 cases and deaths.
  3. There are uncertainties regarding the impact of new variants, vaccine effectiveness, and waning immunity, highlighting the need for continued vigilance.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 19 Apr 21
  1. Increasing vaccine supply is crucial to maintain vaccination rates and prevent the pandemic from resurging when needed.
  2. Extending the length between vaccine doses beyond 16 weeks presents uncertainties, and experts are still unsure of the outcomes.
  3. Monitoring the effectiveness of first doses over time and preparing for potential booster shots post-second dose are crucial for informed decision-making before July.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 12 Apr 21
  1. As vaccination rates increase, the need for rapid screening to prevent outbreaks remains crucial because both vaccines and screening can help control the spread of Covid-19.
  2. The effectiveness of rapid screening in reducing the risk of outbreaks significantly increases as the percentage of vaccinated individuals rises, highlighting the importance of combining vaccination with screening.
  3. There is a potential issue of waning immunity post-vaccination, especially among older populations, which could lead to the re-emergence of Covid-19. This emphasizes the need for a surveillance plan to monitor immunity levels in the vaccinated population and address any possible resurgence.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 01 Apr 21
  1. Australia's success in managing COVID-19 has led to complacency in vaccination efforts, resulting in potential long-term challenges.
  2. Achieving herd immunity is not a guarantee of safety, as the virus can still spread even with high vaccination rates.
  3. Strategic planning and a stronger vaccine strategy are crucial for countries like Australia to navigate the transition from COVID-Zero to a more sustainable approach amidst evolving virus variants.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 24 Feb 21
  1. There is no such thing as a perfectly safe event - caution is always required, and risks are unavoidable.
  2. Even with considerable precautions taken, events can still be risky - the event at issue saw 2.5% of attendees infected.
  3. Testing for COVID-19 is crucial, but flaws in testing protocols can lead to false negatives, impacting event safety measures.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 15 Feb 21
  1. We need to plan for long-term strategies for managing Covid-19 as an endemic disease, considering the possibility that it might never fully go away.
  2. The ongoing mutations in the virus pose a challenge to achieving widespread immunity and point out the importance of developing effective treatments alongside vaccines.
  3. A diplomatic approach is needed in dealing with Covid-19, focusing on finding treatments that can make the disease more manageable in the long run, rather than relying solely on vaccine strategies.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 27 Jan 21
  1. Vaccination has benefits beyond protection that are being overlooked, like conserving scarce vaccine doses by testing for antibodies in individuals who have already had Covid-19.
  2. Public health messages are simplistic and may not account for evolving situations, such as the potential for vaccinated individuals to spread the virus.
  3. Locking up vaccinated individuals without allowing them more freedom can hinder understanding their role in spreading the virus, and a lack of flexibility in responses may lead to behavioral challenges in the future.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 06 Jan 21
  1. Israel's efficient vaccine distribution showcases excellent preparation and organization.
  2. Israel has a unique opportunity to provide insights into the effectiveness of vaccination against COVID-19.
  3. Israel's approach to vaccine distribution may offer hope for addressing long-term problems, such as providing vaccines to neighboring territories.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 04 Jan 21
  1. There is a debate about the effectiveness of administering two vaccine doses versus one, with some evidence showing that a single dose could be adequate in certain situations.
  2. The timing of vaccine doses is crucial, with considerations on how to maximize the number of people vaccinated and the potential risks of delaying the second dose.
  3. Mathematical calculations play a role in determining the efficacy of first doses first strategy, but there are complexities involved, including capacity, prevalence of the virus, and the role of vaccines in reducing spread.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 14 Dec 20
  1. Consideration is being given to whether a single dose of the Covid-19 vaccine could be enough, given the potential benefits of quicker vaccination and less logistical constraints.
  2. The effectiveness of one dose of the vaccine is being debated, as initial data suggests it may offer some protection, but uncertainty remains about how long immunity from a single dose lasts.
  3. Ensuring people receive the second vaccine dose may pose a challenge due to potential beliefs that one dose is sufficient, highlighting the importance of clear communication and tracking systems.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 18 Nov 20
  1. Vaccine dosages are crucial - receiving two doses is necessary to ensure proper immune response and protection for individuals.
  2. Timing of vaccine doses is important - while sticking to the recommended schedule is ideal, there is some flexibility in providing the second dose within a reasonable timeframe.
  3. Good information infrastructure is essential - reliable systems are needed to track who received which vaccine doses and when to ensure effective vaccination management.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 04 Nov 20
  1. Achieving herd immunity through infection can be a challenging policy due to individual behaviors impacting the rate of infection.
  2. To accelerate the spread of Covid-19 for herd immunity, potential strategies include mask prohibitions, creating situations for people to congregate indoors for extended periods, and avoiding widespread testing.
  3. Implementing unconventional and counterintuitive measures like not announcing vaccine progress, encouraging large gatherings such as political rallies, or subsidizing risky activities could be attempts to expedite herd immunity.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 30 Sep 20
  1. Local outbreaks can be controlled with widespread testing and proper data transparency.
  2. Facing challenges with social distancing, universities and prisons have shown success in handling outbreaks through testing and transparency.
  3. Commitment to high data transparency is crucial in dealing with outbreaks and implementing effective testing strategies.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 12 Aug 20
  1. People's behavior plays a significant role in determining how a pandemic like Covid-19 progresses, even more than epidemiological models predict.
  2. Understanding the concept of R0, the basic reproduction number, helps in identifying peak infection points and herd immunity thresholds.
  3. Human behavior can cause fluctuations in the effective reproduction rate of a virus, ultimately leading to an equilibrium point where the virus becomes stable and endemic.
Joshua Gans' Newsletter β€’ 0 implied HN points β€’ 12 Apr 20
  1. Immunity from COVID-19 is a critical assumption in policy discussions, but what if this assumption is wrong? If immunity is not guaranteed, the virus may never go away.
  2. Investing in extensive testing, especially HAVE tests, can still be valuable even if immunity or a vaccine is not a solution. Testing can help contain the spread of the virus and eventually eradicate it.
  3. The possibility of not achieving permanent immunity emphasizes the need for testing as a hedge against uncertainty. Testing, regardless of immunity status, plays a crucial role in managing the pandemic.
Are You Okay? β€’ 0 implied HN points β€’ 21 Nov 22
  1. Vaccination against COVID is essential to protect against severe disease, even with waning immunity from the primary vaccine series.
  2. Flu shots are recommended for managing the flu virus effectively and are a good match for the circulating strains this year.
  3. Boosting the immune system with sleep, proper nutrition, exercise, and other self-care practices can help protect against various viruses.
Are You Okay? β€’ 0 implied HN points β€’ 11 Oct 22
  1. Flu is a serious illness caused by influenza virus with symptoms like fever, cough, and body aches.
  2. Getting the flu shot is crucial every year, with effectiveness ranging from 20% to 60%, to reduce severe disease and mortality.
  3. COVID and flu are spread similarly, but different tests are needed to distinguish them; antivirals like Tamiflu help with flu treatment.
Are You Okay? β€’ 0 implied HN points β€’ 05 Sep 22
  1. New booster shots are designed to reduce the risk of symptomatic infection by producing fresh antibodies against current variants.
  2. People who had COVID in 2020 or 2021 might not benefit significantly from the new booster shot due to existing immunity.
  3. The decision to get the new booster shot should be personalized based on age, health conditions, and time since last COVID shot or infection.
Are You Okay? β€’ 0 implied HN points β€’ 18 Jul 22
  1. During the COVID-19 pandemic, it's important to acknowledge that it's okay to not be okay and to give yourself permission to feel human emotions.
  2. The BA.5 variant is more contagious than previous Omicron subvariants, but not necessarily causing more severe disease. Vaccines still provide good protection against serious outcomes.
  3. To protect against BA.5 and future variants, focus on basic health measures, vaccination, boosters if recommended, and consider options like nasal vaccines and monoclonal antibodies.
Are You Okay? β€’ 0 implied HN points β€’ 11 Jul 22
  1. The BA.5 Omicron subvariant is highly contagious but doesn't seem to be intrinsically more virulent than past variants. So far, the vaccine continues to offer protection against death and serious COVID outcomes against BA.5.
  2. Deciding on vaccinating children under 5 against COVID is nuanced and should be individualized. Although the risks of major vaccine side effects are extremely low, the long-term safety and efficacy for children are not yet fully understood.
  3. It's important to focus on vulnerable populations for vaccination and boosters to protect society as a whole. The data and understanding around COVID vaccination for young children are still evolving, requiring a nuanced approach towards decision-making.
Are You Okay? β€’ 0 implied HN points β€’ 23 May 22
  1. Paxlovid is not a one-size-fits-all solution and its effectiveness varies depending on factors like age, vaccination status, and underlying health conditions.
  2. Using Paxlovid in vaccinated individuals is still being studied, but it has shown anecdotal improvement in symptoms for some high-risk patients.
  3. Some vaccinated patients have experienced a rebound of COVID symptoms after finishing a course of Paxlovid, prompting further research and caution in prescribing.
Are You Okay? β€’ 0 implied HN points β€’ 04 Apr 22
  1. The FDA authorized a second booster shot for specific groups, emphasizing individual responsibility in COVID protection.
  2. Data supports high effectiveness of COVID vaccines in reducing hospitalization rates, especially with more booster shots.
  3. Consulting a primary care provider for personalized advice on receiving additional booster shots is crucial for making informed decisions.
Are You Okay? β€’ 0 implied HN points β€’ 14 Mar 22
  1. High school and college students are experiencing mixed emotions about removing masks, ranging from excitement to worry and empathy for others.
  2. As mask mandates are lifted, individuals are responsible for assessing their own risks and decisions about wearing masks.
  3. Key lessons learned in the age of Omicron include the evolving role of vaccines, the importance of ventilation, the legitimacy of infection-acquired immunity, and the increasing population immunity compared to last year.
Are You Okay? β€’ 0 implied HN points β€’ 15 Feb 22
  1. As COVID-19 restrictions relax, pediatricians are sharing optimistic views on the progress made, including the availability of effective vaccines and the decreasing severity of the virus over time.
  2. Children who have recovered from COVID-19 tend to develop lasting immunity, with studies showing a strong immune response, even greater than adults, in some cases.
  3. The potential harms of prolonged mask wearing on children's development, combined with the psychological impacts of the pandemic, highlight the importance of considering the overall well-being of children when making decisions about COVID-19 precautions.
Are You Okay? β€’ 0 implied HN points β€’ 23 Nov 21
  1. Don't attend events if you have symptoms. Call a doctor and get tested to be sure.
  2. Vaccination and boosting significantly reduce the risk of COVID-19 infection and transmission.
  3. Consider safety measures indoors like rapid testing, ventilation, limited guests, and mask-wearing to reduce COVID-19 spread.
Are You Okay? β€’ 0 implied HN points β€’ 25 Oct 21
  1. Boosters are recommended for certain groups like those over 65 or with chronic conditions, and timing varies depending on the initial vaccine received.
  2. It's important to consider the type of booster based on individual health and risks, with options like sticking with the original vaccine or mixing and matching for added protection.
  3. Side effects from booster shots are similar to initial vaccines, so it's advisable to plan for a day or two for potential reactions like fatigue or arm soreness.
Are You Okay? β€’ 0 implied HN points β€’ 27 Sep 21
  1. The CDC recommends booster shots for specific groups at higher risk of poor outcomes from COVID-19 breakthrough infections, but the decision is complex and based on evolving data.
  2. Recommendations for Moderna and J & J vaccine recipients are still pending, but it's suggested that high-risk individuals consider a third dose, potentially even from a different type of vaccine for additional protection.
  3. The focus should be on trusting the existing vaccines and immune systems to manage COVID-19 risks, rather than solely relying on boosters to eliminate the pandemic threat entirely.
Are You Okay? β€’ 0 implied HN points β€’ 20 Sep 21
  1. The flu is a respiratory illness caused by the Influenza virus, can be severe, and leads to thousands of deaths each year in the U.S.
  2. The effectiveness of the flu vaccine varies from 20-60%, but even when effectiveness is low, it still significantly reduces mortality and morbidity.
  3. It is important to get the flu shot every year, especially this year, to prevent outbreaks that could strain healthcare systems and to protect against the flu and COVID-19.
Are You Okay? β€’ 0 implied HN points β€’ 30 Aug 21
  1. Our immune system naturally fights pathogens like the coronavirus by creating antibodies and memory cells for future protection.
  2. Vaccines offer great protection against severe disease, although breakthrough infections are possible.
  3. Natural immunity from recovering from COVID-19 may also offer protection, but getting vaccinated is still recommended for optimal defense.
Are You Okay? β€’ 0 implied HN points β€’ 23 Aug 21
  1. COVID testing options include rapid antigen tests with high sensitivity for symptomatic adults, and PCR tests for early and late infection detection.
  2. The CDC recommends testing and isolation protocols for fully vaccinated individuals who are sick or exposed to COVID-19, with different requirements based on symptoms.
  3. Vaccinated individuals can still infect others, but likelihood is lower than in unvaccinated individuals; Booster shots are not universally necessary but could benefit some high-risk groups.
Are You Okay? β€’ 0 implied HN points β€’ 28 Jun 21
  1. People enjoy autonomy and want positive affirmations in decisions regarding health recommendations.
  2. It's important to understand that eradicating COVID-19 completely is impossible, but controlling it is feasible through vaccination and other preventive measures.
  3. The key to moving forward in this new era is through vaccinations, staying updated on health screenings, and being aware of the measures needed to control COVID-19.
Are You Okay? β€’ 0 implied HN points β€’ 17 Jun 21
  1. The mRNA vaccines from Pfizer-BioNTech and Moderna work well against the Delta variant, providing strong protection from severe disease and death.
  2. People who received the J & J vaccine may benefit from a single mRNA vaccine dose as a booster, based on similar mechanisms of action with the AstraZeneca vaccine.
  3. It's vital to encourage vaccination, remain calm if fully vaccinated, and put the risk of COVID-19 into perspective by evaluating evolving data and minimizing fear.
Are You Okay? β€’ 0 implied HN points β€’ 01 Apr 21
  1. The vaccines have shown strong effectiveness against symptomatic COVID-19 after full vaccination, making it difficult to contract the disease.
  2. After vaccination, the risk of transmitting the virus and making others sick is extremely low, providing protection for both the vaccinated individual and those around them.
  3. The vaccines have proven to be powerful against COVID-19 variants, with data showing high efficacy in preventing severe disease and even mild cases, emphasizing the importance of vaccination.
Are You Okay? β€’ 0 implied HN points β€’ 18 Mar 21
  1. Currently available vaccines (Pfizer, Moderna, Johnson & Johnson) effectively prevent death, hospitalization, and severe disease from COVID-19, transforming it into a milder illness.
  2. The vaccines demonstrate high efficacy in the real world, significantly reducing rates of death, hospitalization, and overall cases.
  3. Vaccines work well against current variants, especially when wide vaccination coverage is achieved; masking and distancing are still important, even for vaccinated individuals.
Are You Okay? β€’ 0 implied HN points β€’ 08 Mar 21
  1. The COVID-19 vaccines from Pfizer, Moderna, and Johnson & Johnson are highly effective at preventing death, severe disease, and hospitalization.
  2. Vaccine efficacy is about reducing the risk of disease in a vaccinated population compared to an unvaccinated population.
  3. It's better to get any available vaccine rather than wait for a specific one as all vaccines contribute to immunization, move us closer to herd immunity, and allow for some return to normalcy.
Are You Okay? β€’ 0 implied HN points β€’ 25 Feb 21
  1. Take the first vaccine available, as all vaccines effectively prevent death and reduce hospitalization from COVID-19.
  2. Vaccine efficacy percentages are about relative risk, and all approved vaccines are successes of modern medicine.
  3. Currently available vaccines protect against variants, but regular boosters may be necessary in the future.
Are You Okay? β€’ 0 implied HN points β€’ 16 Dec 20
  1. Getting the COVID-19 vaccine can bring feelings of joy, relief, and gratitude, offering hope for a future without the constant worry of the virus.
  2. The duration of immunity from the vaccine and the need for continued mask-wearing are still uncertain, requiring more data and time for observation.
  3. The vaccine administration prioritizes certain groups, individuals with allergies may need to be cautious, and those who have had COVID-19 may still benefit from getting vaccinated.
Are You Okay? β€’ 0 implied HN points β€’ 09 Dec 20
  1. Prioritize getting vaccinated for COVID-19 as it's proven to be 95% effective with an excellent safety profile.
  2. Continue practicing safe behaviors such as wearing masks and distancing until widespread vaccination is achieved.
  3. Encourage others to get vaccinated, stay informed with facts, and be prepared for a winter of adjustments in social gatherings.